Lise Lund Kjems
Nessuna posizione attualmente
Patrimonio netto: 21 828 $ in data 31/05/2024
Storia della carriera di Lise Lund Kjems
Precedenti posizioni note di Lise Lund Kjems
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| CYCLO THERAPEUTICS, INC. | Direttore Tecnico/Scientifico/R&S | 27/09/2021 | 01/04/2023 |
| ALBIREO PHARMA, INC. | Corporate Officer/Principal | - | - |
Formazione di Lise Lund Kjems
| University of Copenhagen | Doctorate Degree |
Statistiche
Distribuzione geografica
| Stati Uniti | 3 |
| Danimarca | 2 |
Posizioni
| Chief Tech/Sci/R&D Officer | 1 |
| Doctorate Degree | 1 |
| Corporate Officer/Principal | 1 |
Settori
| Health Technology | 3 |
| Consumer Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| CYCLO THERAPEUTICS, INC. | Health Technology |
| Aziende private | 1 |
|---|---|
Albireo Pharma, Inc.
 Albireo Pharma, Inc. Pharmaceuticals: MajorHealth Technology Albireo Pharma, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of novel bile acid modulators for the treatment of orphan pediatric liver diseases and gastrointestinal disorders. Its pipeline products include Odevixibat, A3384, and Elobixibat. The company was founded by Jan Peter Mattsson and Per-Göran Gillberg on December 8, 2003 and is headquartered in Boston, MA. | Health Technology |
- Borsa valori
- Insiders
- Lise Lund Kjems
- Esperienza
